期刊文献+

益肝消癥散抗慢性肝炎肝纤维化临床研究 被引量:1

Clinical Study on Resisting Fibrosis Caused by Chronic Hepatitis with YGXZS
下载PDF
导出
摘要 Objective:Observing the effect and side-effect of YiGanXiaoZhengSan (YGXZS) on fibrosis caused by chronic hepatitis and evaluating the anti-fibrosis impact of YGXZS,meanwhile,to study the relation between the syndrome classification and liver fibrosis indexes.Method:50 patients with hepatic fibrosis of chronic hepatitis were divided into the treated group and the control group randomly,the treated group including 30 cases were treated with YGXZS,the efficacy was compared with that of 20 cases treated with common western medicine of protecting liver.Duration of treatment were 3 months.After treatment the serum indexes of hepatic function and hepatic fibrosis were detected.Result:The level of serum HA,PCⅢ,LN,Ⅳ-C in the treated group decreased remarkably(P<0.01),control group had no obvious change of these indexes(P>0.05).There was significant difference between the two groups (P<0.01).Conclusion:YGXZS can treat chronic hepatitis and delay and ease the development of hepatic fibrosis. Objective:Observing the effect and side-effect of YiGanXiaoZhengSan (YGXZS) on fibrosis caused by chronic hepatitis and evaluating the anti-fibrosis impact of YGXZS,meanwhile,to study the relation between the syndrome classification and liver fibrosis indexes.Method:50 patients with hepatic fibrosis of chronic hepatitis were divided into the treated group and the control group randomly,the treated group including 30 cases were treated with YGXZS,the efficacy was compared with that of 20 cases treated with common western medicine of protecting liver.Duration of treatment were 3 months.After treatment the serum indexes of hepatic function and hepatic fibrosis were detected.Result:The level of serum HA,PCⅢ,LN,Ⅳ-C in the treated group decreased remarkably(P<0.01),control group had no obvious change of these indexes(P>0.05).There was significant difference between the two groups (P<0.01).Conclusion:YGXZS can treat chronic hepatitis and delay and ease the development of hepatic fibrosis.
出处 《江西中医学院学报》 2004年第2期40-43,共4页 Journal of Jiangxi College of Traditional Chinese Medicine
关键词 益肝消癥散 慢性肝炎 肝纤维化 毒副作用 药物治疗 Chronic hepatitis Hepatic fibrosis YGXZS Anti-fibrosis Clinical study
  • 相关文献

参考文献12

二级参考文献35

共引文献14408

同被引文献20

引证文献1

二级引证文献5

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部